Entering text into the input field will update the search result below

FDA grants emergency clearance for Regeneron's COVID-19 threapy

  • Regeneron Pharmaceuticals (NASDAQ:REGN) says its COVID-19 antibody cocktail casirivimab and imdevimab administered together has received Emergency Use Authorization from the U.S. Food and Drug Administration to treat patients who are not hospitalized but are at high risk of developing the

Recommended For You

Related Stocks

SymbolLast Price% Chg
LLY
--
REGN
--